Novo Nordisk further lowers prices for weight loss, diabetes drugs for those who pay cash
Facing elevated competitors within the weight loss market and intense strain from President Donald Trump, Novo Nordisk introduced Monday that it’s reducing prices for its blockbuster weight problems and diabetes…